(Q84567412)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629661%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629661%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

main subject

phase II clinical trial

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629661%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

4

Mats Jerkeman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629661%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

11

Hans Hagberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629661%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Francesco d'Amore

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629661%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Thomas Relander

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629661%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Hervé Tilly

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629661%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Anders Osterborg

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629661%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Franck Morschhauser

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629661%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Martin Gramatzki

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629661%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Martin Dreyling

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629661%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Bo Bang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629661%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

14 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629661%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Haematology

7 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629661%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

150

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629661%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629661%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

565-573

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629661%20AND%20SRC:MED&resulttype=core&format=json

10.1111/J.1365-2141.2010.08298.X

7 February 2020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629661%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference